ICAM-3 endows anticancer drug resistance against microtubule-damaging agents via activation of the ICAM-3-AKT/ERK-CREB-2 pathway and blockage of apoptosis
Keywords: ICAM-3; Akt; ERK; CREB-2; Drug resistance; Apoptosis; Paclitaxel; Vincristine;